In talks with 3 medical device cos to manufacture ventilators: MG Motor India
PTI, Apr 5, 2020, 11:13 AM IST
New Delhi: MG Motor India is in talks with three medical device makers, including GE, to produce ventilators at its Halol facility to help meet demand during the coronavirus pandemic, according to a top company official.
The company, which has also launched a hunt for a low-cost ventilator design through a challenge, is also developing its own ventilator and hopes to be ready with a prototype within a week as part of its three-pronged approach to get into ventilator manufacturing considering the shortage during this health crisis.
“We are talking to medical equipment companies like GE and some other companies, which already have established and approved designs. If they can tell us, then we can start manufacturing based on their design in our plant,” MG Motor India President and Managing Director Rajeev Chaba told PTI.
He further said all three companies have responded positively and that can be the fastest solution if there is a design approved by the medical body already and everything is in place.
Besides, he said, “In the last 10 days, our engineering team is busy making a prototype. I’m happy to say that we have already made the drawings and everything. We have talked to the medical experts, our prototype should be ready in the next one week. If that prototype is approved, then our own designed ventilator can be manufactured by MG in India.”
However, this approach will take some more time as it needs regulatory approvals, he added.
The company has also announced a Rs 10 lakh grant through its “challenge to youngsters and young engineers that if they want to make a low-cost design, we are going to help them”, Chaba said.
On the manufacturing of ventilators, he said MG Motor India will create infrastructure at its Halol facility and would even carve out a separate unit if need be.
“If the car demand is not too much in future then my existing manpower can work on this project. We may have to have some new capex for this kind of a thing, although I don’t know exactly how does that look like. But then we will look at putting the right capex into this project to make the ventilators,” he said.
On the other hand, Chaba said that if the demand for the company’s vehicles continues and have waiting period as it is now and “if our people get busy making the cars, I feel we would carve out a separate unit for ventilators.”
“If we have to recruit more people, we will do it to have more people into this project because this virus is not going to go away in the next three years or so,” he said, stressing that even if vaccines are developed for the coronavirus it is going to take long to make them available at a mass scale.
He further said that in India at the moment there is a huge gap between demand and supply for ventilators.
“We don’t want to make this as a profit making venture. If we can keep it low cost and operate at breakeven and supply to the community, to the government, it will be a great service,” Chaba said.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Royal Enfield forays into electric bike segment; unveils first model under Flying Flea brand
Maruti Suzuki looks to cash in on ‘few lakh marriages’ in Nov to carry festive sales momentum
Auto sales grow in mid-to-high single digits during Navratras, rural sales muted: Report
Car makers witness record sales on Dhanteras; Oct bookings up by 30%
State not empowered to frame rules for motor driving schools: HC
MUST WATCH
Latest Additions
Rahul Gandhi to attend caste census meeting in Hyderabad today
Udupi: Gas cylinder explosion during party causes extensive damage in apartment
Stay Safe Online: Tips to avoid cyber fraud!
FIR against Sanjay Raut’s brother for remarks against Shiv Sena’s woman leader
Kodagu murder case accused escapes from police in Hyderabad
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.